Skip to main content
Premium Trial:

Request an Annual Quote

Olink, Uppsala Collaborate on Sample Prep for Next-Gen Sequencing

NEW YORK (GenomeWeb News) – Olink and researchers from Uppsala University in Sweden have formed a new firm, called Olink Genomics, with the goal of commercializing technology for sample-preparation applications in the next-generation sequencing market, Olink said yesterday.
 
The new subsidiary of Olink intends to launch the Selector Technology, which researchers from Olink and Uppsala have developed for sequence-selective sample prep. Olink said that the technology would be rolled out as a service and as reagent kits.
 
The firm said in a statement that whole-genome sequencing using the newest generation of DNA sequencers from firms such as Roche/454, Illumina, Applied Biosystems, and Helicos “is not yet within reasonable cost. This has created a rapidly increasing demand for sample preparation techniques that enable selective enrichment of genomic regions, for example candidate regions that may contribute to genetic disease, and genes involved in cancer, for subsequent DNA sequencing.”
 
Olink noted that the acadmic co-founders of the new subsidiary contributed unique software to support probe development.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more